Patents by Inventor Matthew Sam Morrison

Matthew Sam Morrison has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Screening and monitoring the progression of type 2 diabetes by the molecular identification of human gut flora using FTA as a faecal collection device
    Patent number: 10982290
    Abstract: Disclosed is a method for detecting and quantifying gut flora derived from human faeces, comprising acquiring a solid support containing human faeces; optionally amplifying nucleic acid from the human faeces; and detecting and quantifying the presence of gut flora of interest. Also disclosed is a method for assessing whether a person has type-2 diabetes as well as a kit for detecting and quantifying gut flora from human faeces, comprising a solid support for collecting human faeces; and primer pairs for amplifying 16S rRNA sequence from bacteria of interest.
    Type: Grant
    Filed: July 23, 2015
    Date of Patent: April 20, 2021
    Assignee: Global Life Sciences Solutions Operations UK Ltd
    Inventors: Jeffrey Kenneth Horton, Peter James Tatnell, Matthew Sam Morrison, Alan Stuart Pierce
  • Screening and Monitoring the Progression of Type 2 Diabetes by the Molecular Identification of Human Gut Flora using FTA as a Faecal Collection Device
    Publication number: 20170211130
    Abstract: Disclosed is a method for detecting and quantifying gut flora derived from human faeces, comprising acquiring a solid support containing human faeces; optionally amplifying nucleic acid from the human faeces; and detecting and quantifying the presence of gut flora of interest. Also disclsoed is a method for assessing whether a person has type-2 diabetes as well as a kit for detecting and quantifying gut flora from human faeces, comprising a solid support for collecting human faeces; and primer pairs for amplifying 16S rRNA sequence from bacteria of interest.
    Type: Application
    Filed: July 23, 2015
    Publication date: July 27, 2017
    Inventors: Jeffrey Kenneth Horton, Peter James Tatnell, Matthew Sam Morrison, Alan Stuart Pierce
  • IN VIVO IMAGING AGENTS FOR MET RECEPTOR TYROSINE KINASE
    Publication number: 20090274623
    Abstract: Provided are in vivo imaging agents comprising muteins of hTLc having detectable binding affinity for c-Met or a domain thereof, coupled to a signal generator, and the mutein coupled to a signal generator is disposed in a pharmaceutically acceptable carrier. Also provided are diagnostic methods using in vivo imaging agents comprising muteins of hTLc having detectable binding affinity for c-Met or a domain thereof.
    Type: Application
    Filed: January 30, 2008
    Publication date: November 5, 2009
    Applicant: GENERAL ELECTRIC COMPANY
    Inventors: Clifford L. Smith, Faisal Ahmed Syud, Brian Duh-Lan Lee, Matthew Sam Morrison, Michael Ernest Marino, Jason William Castle, Paul Schaffer, Gabriele Matschiner, Andreas Hohlbaum, Martin Huelsmeyer, Stefan Trentmann